Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)

Kwang Dong Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	213,687	218,039	297,799	244,840	305,229	421,076
Market Cap Growth	-26.78%	-26.78%	21.63%	-19.79%	-27.51%	59.98%
Enterprise Value	373,303	335,136	283,794	196,173	300,829	390,078
Last Close Price	5440.00	5440.00	7430.00	5879.78	7209.84	9813.83
PE Ratio	5.38	5.39	8.06	10.13	12.71	9.28
Forward PE	-	14.32	14.32	14.32	14.32	14.32
PS Ratio	0.13	0.13	0.20	0.17	0.23	0.34
PB Ratio	0.37	0.35	0.51	0.45	0.58	0.84
P/TBV Ratio	0.40	0.40	0.59	0.49	0.63	0.91
P/FCF Ratio	-	-	6.54	9.80	23.97
P/OCF Ratio	-	-	3.90	5.56	18.45
EV/Sales Ratio	0.23	0.20	0.19	0.14	0.23	0.31
EV/EBITDA Ratio	8.22	7.51	5.16	3.75	5.10	5.88
EV/EBIT Ratio	12.09	11.14	6.75	5.13	6.70	8.37
EV/FCF Ratio	-4.25	-	-	5.24	9.66	22.21
Debt / Equity Ratio	0.46	0.46	0.40	0.25	0.25	0.22
Debt / EBITDA Ratio	6.41	6.41	4.29	2.64	2.24	1.65
Debt / FCF Ratio	-	-	-	3.69	4.24	6.25
Asset Turnover	1.46	1.46	1.51	1.58	1.56	1.53
Inventory Turnover	6.62	6.62	6.95	7.34	6.58	6.21
Quick Ratio	0.95	0.95	1.03	1.23	1.32	1.24
Current Ratio	1.55	1.55	1.46	1.71	1.81	1.93
Return on Equity (ROE)	6.94%	6.94%	6.94%	4.97%	4.96%	9.60%
Return on Assets (ROA)	1.67%	1.67%	2.62%	2.63%	3.28%	3.59%
Return on Capital (ROIC)	2.18%	2.18%	3.48%	3.56%	4.42%	4.97%
Return on Capital Employed (ROCE)	4.20%	4.20%	6.80%	6.60%	8.00%	8.80%
Earnings Yield	18.94%	18.57%	12.41%	9.87%	7.87%	10.78%
FCF Yield	-41.13%	-40.31%	-15.62%	15.29%	10.20%	4.17%
Dividend Yield	1.84%	-	-	1.70%	1.39%	1.02%
Payout Ratio	9.90%	9.90%	11.11%	16.99%	17.10%	6.98%
Buyback Yield / Dilution	1.10%	1.10%	1.44%	0.11%	-1.48%	-2.24%
Total Shareholder Return	2.94%	1.10%	1.44%	1.82%	-0.10%	-1.23%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.